"We never know who is going to get cancer, and it's never one factor that causes cancer." ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...
New research decoding their DNA is helping to shed light on how the collapse and slow, scattered return of herds to the ...
Scientists estimate that humans could theoretically live 146 to 194 years if most ageing processes were eliminated, but DNA ...
Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.
Myriad Genetics, SOPHiA GENETICS and AstraZeneca are collaborating to advance Myriad’s prostate cancer genomic instability ...
About 5 to 10% of breast cancer cases are linked to inherited gene mutations, which is why doctors recommend all women ...
Head and neck squamous cell carcinoma (HNSCC) frequently develops in the oral and upper aerodigestive regions following ...
If you had looked at Myriad Genetics in October 2025, seen bullish talk about genomics, AI and precision medicine, then ...
A new AI model shows promise for predicting genetic ALS risk regardless of family history or known mutations. Capsule Networks can distinguish people with ALS from unaffected individuals, with a high ...
Oryza rufipogon is an ordinary-looking wild grass found today in parts of China, India and Southeast Asia. More than 8,000 ...
This study presents RovHer, a heritability-optimized scoring method for estimating the functional impact of rare variants, which is applied to the UK Biobank to demonstrate its ability to enrich for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results